The Top Line cover image

Misconduct and the future of neurodegenerative disease research

The Top Line

CHAPTER

Challenges and Future Directions in Parkinson's Drug Targeting

This chapter explores the challenges of targeting alpha-synuclein in Parkinson's disease and evaluates the limitations of current immunotherapy strategies. It highlights the need for innovative approaches in drug development to effectively address this complex target in neurodegenerative treatments.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner